NCT03093987

Critical Care Ultrasound Oriented Shock Treatment in ICU

Completed NA Last updated 1 November 2017

What this trial tests

NA trial testing Critical care ultrasound in Shock in 150 participants. Completed in 28 October 2017.

Timeline

5 April 2017

Primary endpoint
28 October 2017

28 October 2017

Quick facts

Lead sponsor	West China Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	150
Start date	5 April 2017
Primary completion	28 October 2017
Estimated completion	28 October 2017
Sites	1 location across China

Drugs / interventions tested

• Critical care ultrasound

Conditions studied

• Shock — all drugs for Shock →

Sponsor

West China Hospital

Who can join

18 and older, any sex, with Shock. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective

To investigate whether critical care ultrasound oriented shock management in shock patients in intensive care unit(ICU) can improve outcome.

Methods

Randomized controlled research. Patients were randomly allocated to two groups. In the critical care ultrasound oriented shock management group (CUSS group), treatment was oriented by the findings of critical care ultrasound in each shock phase, while in the control group the decisions about the monitoring and management were made by the clinical team. The goal of treatments in both groups were decreasing lactate by 20% or more per 2 hours for the Optimization phase in shock management, and no increase lactate level when removing the fluid in de-escalation phase. The primary outcome measure were hospital mortality and 28-day mortality, the secondary outcome measure were the length of ventilation and the length of ICU stay.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Critical Care Ultrasound Oriented Shock Treatment in Intensive Care Unit: A Randomized Controlled Trial
   Yin W, Qin Y, Zou T, Zeng X, et al · · 2021 · DOI 10.21203/rs.3.rs-141725/v1